Journal
GENES AND ENVIRONMENT
Volume 43, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s41021-021-00188-0
Keywords
CRISPR/Cas9; Genome editing; Breast Cancer; Therapy
Categories
Ask authors/readers for more resources
The use of CRISPR/Cas9 has revolutionized genome editing in cancer research, allowing for the identification and correction of mutations associated with tumor progression. Various novel strategies utilizing CRISPR/Cas9 have shown promise in treating breast cancer in in vitro and in vivo systems.
CRISPR/Cas9 has revolutionized genome-editing techniques in various biological fields including human cancer research. Cancer is a multi-step process that encompasses the accumulation of mutations that result in the hallmark of the malignant state. The goal of cancer research is to identify these mutations and correlate them with the underlying tumorigenic process. Using CRISPR/Cas9 tool, specific mutations responsible for cancer initiation and/or progression could be corrected at least in animal models as a first step towards translational applications. In the present article, we review various novel strategies that employed CRISPR/Cas9 to treat breast cancer in both in vitro and in vivo systems.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available